Swedish Orphan Biovitrum AB (publ) drugs

6 results

  • gamifant - emapalumab - lzsg injection

    (Emapalumab-Lzsg)
    Swedish Orphan Biovitrum Ab (Publ)
    Gamifant treats primary hemophagocytic lymphohistiocytosis (HLH) in adults and children with refractory, recurrent, or progressive disease, and HLH/macrophage activation syndrome in Still's disease (including sJIA) with inadequate response or intolerance to conventional therapy.
    Medication Details
    Drug Interactions

  • kineret - anakinra injection, solution

    (Anakinra)
    Swedish Orphan Biovitrum Ab (Publ)
    Kineret treats moderately to severely active rheumatoid arthritis in adults 18+ who have failed one or more DMARDs, reducing symptoms and slowing joint damage. It also treats Neonatal-Onset Multisystem Inflammatory Disease (NOMID) and Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
    Medication Details
    Drug Interactions

  • orfadin - nitisinone capsule

    (Nitisinone)
    Swedish Orphan Biovitrum Ab (Publ)
    Orfadin treats hereditary tyrosinemia type 1 (HT-1) in adults and children, used alongside dietary restriction of tyrosine and phenylalanine.
    Medication Details
    Drug Interactions

  • synagis - palivizumab injection, solution

    (Palivizumab)
    Swedish Orphan Biovitrum Ab (Publ)
    Synagis prevents serious lower respiratory tract disease caused by RSV in pediatric patients: premature infants (≤35 weeks gestation, ≤6 months old), or children ≤24 months with bronchopulmonary dysplasia requiring treatment, or hemodynamically significant congenital heart disease. Not indicated for RSV treatment.
    Medication Details
    Drug Interactions